In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Boston Scientific acquires EndoTex Interventional Systems

Executive Summary

Upping its 20% shareholding, Boston Scientific has now acquired EndoTex Interventional Systems, a company that is developing devices to treat carotid artery disease. BS issued 5mm shares worth $90mm to EndoTex stockholders, as well as $10mm in cash.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Earnout
    • Partial Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register